At a glance
ClinicalIndex Comparison RecordN/ACompleted· 121 enrolled
Drug / intervention
AgaMatrix Blood Glucose Monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
User Study for the Evaluation of an Enhanced Meter Feature Using an AgaMatrix BGMS
In Brief
A clinical study evaluating AgaMatrix Blood Glucose Monitor for Diabetes Mellitus. Completed, enrolled 121 participants across 1 site.
Detailed Summary
This enhanced meter feature raises awareness among patients by providing additional information regarding their glycemic control in between Healthcare Professional visits. This information may facilitate increased dialogue between patient and Healthcare Professional and can remind patients of the importance of glycemic control. This study will evaluate a user's ability to use the enhanced meter feature.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 2013
Enrollment StartJan 2014
Primary CompletionFeb 2014
Study CompletionMar 2014
TodayJul 2026
First PostedJun 28, 2013
Enrollment StartJan 1, 2014
Primary CompletionFeb 1, 2014
Study CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 13.0 years ago
Interventions
AgaMatrix Blood Glucose Monitordevice